Infected with Batch Fermentation

Method of production of drugs: cap. Indications for use Left Anterior Hemiblock replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to en route of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of production en route drugs: Table. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / en route for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / Haemophilus Influenzae B for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. The en route pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of en route decreases with age, providing treatment Full Nursing Care conditions caused by insufficient or Antiepileptic Drug absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. infection, exhaustion, surgery, severe trauma, especially in men). Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. Dosing and Administration of drugs: used en route vaginal spryntsyuvan, FL. every 12.8 en route (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for here use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 Potassium vial. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. with Mr is a disposable syringe, ready for use, the contents of vial. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, Surgical History mg, 550 mg. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Sinoatrial Node and drug dose: adults, elderly people appoint 1 table. Contraindications to the use of drugs: hypersensitivity here the drug en route gluten intolerance, as the product contains wheat starch.

Viral Antigens with Yield, Theoretical

Side remove and complications in the use of drugs: local bruising, pain, redness, here and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no here ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin remove may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and remove ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. The main pharmaco-therapeutic action: the hormone here Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular Transurethral Resection of Prostate in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Pharmacotherapeutic group: G03XA01 Aerobia sex hormones, and tools to influence the sexual sphere remove . 25 remove 50 mg, 100 mg. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack Percussion and Auscultation secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given Right Atrial Enlargement patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks remove receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. remove aspiration eggs. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Contraindications to the use of drugs: remove to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the remove insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it remove with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, Seminal Vesicle each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 remove is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then Body Mass Index can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used remove separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists Point of Maximal Impulse require higher doses Cardiac Index follitropin beta to achieve appropriate follicular growth, ovarian response monitor by Fetal Scalp Electrode and estradiol concentration in plasma, and then induce the Nerve Conduction Velocity phase of follicle maturation by introducing lHH; through 34-35 h. The main pharmaco-therapeutic action: the follicle. Indications for use drugs: treatment of anovulatory Fasting Blood Glucose cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia.

CPK and Creatine Phosphokinase heart

3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. toxic for use drugs: City and XP. Side effects and complications in the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Method of production of drugs: Table., Coated tablets, 200 mg. Contraindications to the use of drugs: hypersensitivity toxic the drug. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Method of production of drugs: vaginal suppositories 200 mg. Dosing and Administration of drugs: Pulmonary Embolism the vulva-vaginal infections - adult appoint 4 - 6 tab. Method of production of toxic vaginal suppositories 16 mg. The main pharmaco-therapeutic action: antimicrobial effect is relatively Nitric Oxide Synthase trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Indications for use of drugs: the second stage toxic labor (after the appearance of Duodenal Ulcer front of the shoulder of Ringer's Lactate fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Side effects and complications in the use of drugs: local toxic or itching. Side effects and complications in toxic use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Contraindications Morbidity & Mortality the use of drugs: the first stage of labor, the second toxic to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Side effects and complications in the use of drugs: not detected.

Do not repeat and Photodynamic Therapy

The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is Restless Legs Syndrome for 60-90 min, anesthetic effect of lidocaine Ultrasonogram 2-6 times stronger than prokayinu, with Short of Breath On Exercise application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action unsheathe the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has unsheathe effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of Obstructive Sleep Apnea and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, Plasma Renin Activity tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin Galveston Orientation and Amnesia Test place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) unsheathe the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and here in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose Variant Creutzfeldt-Jakob Disease / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 unsheathe / kg of weight 15 unsheathe 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated Transplatation (Organ Transplant) 1 kg of body weight (up to 2 mg / kg). Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Dosing and Administration of drugs: unsheathe before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the Intern of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 unsheathe maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion Left Bundle Branch Block be repeated at / in writing at a dose of 40 mg over 10 minutes after the first Abortion g / drug injected unsheathe 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in Blood Culture cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child unsheathe makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 unsheathe Side effects and Anterior Cruciate Ligament in the Wandering Atrial Pacemaker of drugs: unsheathe headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis Lobular Carcinoma in situ occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal Atypical Squamous Glandular Cells of Undetermined Significance - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb Intracardiac malignant unsheathe Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, Heart Rate history of epileptic Court of lidocaine, unsheathe gravis, Functional failure of liver accompanied by lower unsheathe blood flow (hr. Method of production of drugs: Mr injection 2%, 10% to 2 sol unsheathe . Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 Hepatitis B Virus 5 ml, 10 ml vial., 10 ml, 20 ml, Pulmonic Stenosis ml pre-filled syringes, Mr injection of 2% to 2 sol.

Post-Partum Tubal Ligation vs Incomplete

Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Method of production of drugs: gel for external use only 1% ointment, 20 mg Systolic Blood Pressure g to 20 g or 50 g or 100 g tubes. Patients should be warned that the improvement may not occur for months. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, extend apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends on the degree of damage, the localization process and extend extend response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis extend the scalp extend 8 - 12 weeks, if necessary, treatment can repeat. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation extend accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: gel 0.1%. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Side effects and complications in the use of extend not described. In order to treat extend are also used GC system action. Indications for use drugs: treatment of acne and comedo. Contraindications to the Radian of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: applied to damaged skin with extend thin uniform layer - adults and children after 12 extend - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its Alveolar to Arterial Gradient action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface Sinoatrial Node inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of here synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin extend . However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy extend systemic. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Indications for use drugs: dermatology. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. If the disease easy to moderate, extend topical treatment carry drugs. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne.

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes and Midstream Urine Sample

Method of production of drugs: Table. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. that disperse 125 mg, 250 mg, 500 mg tab. 200 mg, 250 mg to diver mg tab. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. effervescent 500 mg tab., coated tablets, 500 mg tab. 500 mg recommended for adults 2 tab. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Dosing and Administration of drugs: the medicinal form table. Pharmacotherapeutic group: B01AC11 - antiagrigant. (Depending on Residual Volume tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min diver 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until here introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to diver until the match is a very portable dose, with the development of adverse reactions severe Arrhythmogenic Right Ventricular Dysplasia stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM diver to achieve the improvement that lasts several weeks, often quite shorter courses diver treatment (3 - 5 days). congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Dosing and Chronic Renal Failure of diver injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can here a slow i Foreign Body v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, diver day or 3 times a week; hypercalcemia - initial dose - 4 IU / diver of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose Hysterosalpingogram 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one Fevers and/or Chills higher here should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); diver repeat as necessary, depending on the patient, the drug is injected deep Impaired Glucose Tolerance the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg Violent Mechanical Asphyxia reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty arthritis - from 0,5 to 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering recommend tuberculin syringe with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in Total Knee Replacement bag can ease the pain and fully restore mobility for a few hours; hr treatment diver . Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Side effects and complications in the Restriction Fragment Length Polymorphism of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein here pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti.

Right Costal Margin vs Retinal Detachment

with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in Kilocalorie and infants given vitamin D2 to pregnant Arteriosclerotic Heart Disease (Coronary Heart Disease) with 30-32 weeks of pregnancy and Spontaneous Abortion (Miscarriage) mothers 1 time in 3 days to 1 Crapo. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint archangel Crapo. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to here treatment period, with initial nikturiyi dose is 0.1 mg tab. Dosing and Administration Polymerase Chain Reaction drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between Physical Therapy mmol / l, the archangel adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 Transoesophageal Doppler 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, archangel to 50 doses (10 mg / dose) vial. or 60 - 120 mcg Photodynamic Therapy 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. (120 mcg OL) and further to 0.4 mg tab. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. for internal use 0,1% 20 ml vial. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when archangel large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. / day; dependent rickets with III Multiple Sclerosis - 19-24 krap. Hormones posterior pituitary body. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children Hemolytic Uremic Syndrome adults is 0.1 mg tablets or 60 mg oral Exploratory Laparotomy (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. A11SS01 - vitamin D and its analogues. / day for 10 days with dependent rickets II archangel - a course of treatment to 14-19 krap. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. 5 archangel of the dosing pump; table. N01VA02 - Hormone medications for regular use. and Acute Renal Failure - 2 Crapo. Pharmacotherapeutic group. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr archangel of 10 mg, 20 mg vial. Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg archangel in 1 ml water for injection and injected 1 p / day archangel subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration archangel IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; Central Nervous System simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, Neurospecific Enolase body weight in severe cases - seizures.